+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Global Health that operates Medanta Hospitals to open its ₹2,205 cr IPO on November 3

Oct 28, 2022, 15:17 IST
  • The IPO consists of a fresh issue of ₹500 crore and an offer for sale of up to ₹1,705 crore through selling 5.08 crore equity shares by the company's shareholders and promoters.
  • The price band of the IPO is set at ₹319-336 a share.
  • The proceeds from the IPO will be utilised towards investment in subsidiaries -- Global Health Patliputra and Medanta Holdings in the form of debt or equity for payment of debt.
Advertisement
Hospital chain company Global Health that operates under the brand ‘Medanta’ will open its IPO for subscription on November 3 and close on November 7.

The total issue size of the IPO is ₹2,205 crore which includes fresh issue of ₹500 crore; and an offer for sale of up to ₹1,705 crore via sale of 5.08 crore equity shares by the company's shareholders and promoters.

The price band of the IPO is set at ₹319-336 a share.

The proceeds from the IPO will be utilised towards investment in two of its subsidiaries -- Global Health Patliputra and Medanta Holdings in the form of debt or equity, for payment of debt.

The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology. Global Health is backed by private equity investors such as Carlyle Group and Temasek.

Advertisement

It operates five hospitals under the Medanta brand in Gurugram, Indore, Ranchi, Lucknow and Patna. It has another hospital under construction at Noida.

While Covid-19 has impacted the health of the company, its profitability has turned around dramatically in the last two fiscal years.
Particulars Revenue Profit
Edit
FY22₹2,166 crore ₹196 crore
FY21₹1,446 crore ₹28.9 crore
FY20₹1,500 crore ₹36 crore
However, the risk of new future variants remains and may impact its financial condition.

“Further, as a result of the detection of new strains, evolving variants such as the ‘Omicron variant’ and subsequent waves of Covid-19 infections throughout the world, we may be subject to further lockdowns or other restrictions in the subsequent years, which may adversely affect our business operations,” said the company in the red herring prospectus.

Another drawback concerning the firm is continuing losses by subsidiaries, which may impact the parent company.

“If these subsidiaries do not become profitable, and are not able to raise capital either through debt or equity, their operations may be affected and this will have an adverse effect on our company’s financial performance and results of operations,” said the company in the draft filing.
Advertisement
PeersTotal income in FY22% return in 2022
Edit
Apollo Hospitals Enterprise ₹14,740 crore -8%
Fortis Healthcare₹5,744 crore -9%
Max Healthcare Institute ₹4,058 crore 28%
Narayana Hrudayalaya₹3,735 crore 22%
Global Health ₹2,205 crore


SEE ALSO: The growth story behind half a billion dollar bets on 'regional' Indian spice makers
Historic decision, red-letter day – BCCI’s pay equity decision wins hearts of Smriti Irani, Sachin Tendulkar, Mithali Raj and more
You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article